Sheel Biotech shareholders and shareholding pattern
NSE: SHEELCommercial Services & Supplies
Last close ₹58.95down ₹1.10 (1.83%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹60.05.
52-week range of traded prices to 23 Oct 2026
₹37.80Low, 1 Apr 2026₹86.50High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹120 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 May 2026
- 10.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 28 May 2026
- 9.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day.
- 4,000
Who owns Sheel Biotech, filing by filing
Per cent of the company's shares. Every filing on record, from Mar 2026; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters72.31%
- Indian institutions9.66%
- Individuals and others18.03%
Shareholding pattern, per cent
- Promoters
- Indian institutions
- Individuals and others
| Per cent | Mar 2026Filed 10 Apr | Sep 2026Filed 13 Oct |
|---|---|---|
| 72.30% | 72.31% | |
| Indian promoters | 72.30% | 72.31% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 27.70% | 27.69% |
| Shares in issue | 2,03,52,550 | 2,03,52,550 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 1,49,90,350 | 1,49,52,350 |
| Promoters' shares locked in | 1,45,40,250 | 1,45,02,250 |
A dash is a line the filing did not state.
Sheel Biotech promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is SANJAY CHANDAK, 19.57%. The filing names 11 more members with no shares.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| SANJAY CHANDAKIndividuals and Hindu undivided families | 19.57% | 39,82,375 | 97.40% |
| SATYA NARAYAN CHANDAKIndividuals and Hindu undivided families | 14.84% | 30,21,000 | 97.04% |
| DIVYE CHANDAKIndividuals and Hindu undivided families | 10.73% | 21,84,000 | 98.72% |
| SUMEET CHANDAK HUFIndividuals and Hindu undivided families | 8.25% | 16,79,300 | 100.00% |
| SHEELA CHANDAKIndividuals and Hindu undivided families | 5.18% | 10,55,250 | 100.00% |
| NEHA CHANDAKIndividuals and Hindu undivided families | 5.10% | 10,37,925 | 100.00% |
| VITRO BIOTECHNOLOGIES LTDIndian companies, trusts and others | 3.81% | 7,75,250 | 100.00% |
| JAYSHEE INVESTMENT PVT LTDIndian companies, trusts and others | 1.59% | 3,24,450 | 100.00% |
| AMIT CEMENT PRIVATE LIMITEDIndian companies, trusts and others | 1.51% | 3,08,000 | 100.00% |
| BLUE OCEAN REALESTATES PRIVATE LIMITEDIndian companies, trusts and others | 1.51% | 3,06,600 | 100.00% |
| Mrs. Sunita ChandakIndividuals and Hindu undivided families | 0.12% | 24,000 | 0.00% |
| Archana DodiaIndividuals and Hindu undivided families | 0.05% | 10,000 | 0.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Sheel Biotech, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2026Filed 10 Apr | Sep 2026Filed 13 Oct |
|---|---|---|
| AARTH AIF GROWTH FUNDAlternative investment funds | 3.20% | 4.36% |
| BHARAT VENTURE OPPORTUNITIES FUNDAlternative investment funds | 3.12% | 3.12% |
| BAKUL CHATURBHAI LIMBASIYAResident individuals, over ₹2 lakh at face value | – | 1.59% |
| SANSHI FUND-IAlternative investment funds | 1.97% | 1.48% |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.